Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a specialty finance company with a market capitalization of $1.17 billion and trading near its 52-week high of $18.35, announced the issuance of $350 ...

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

Bain Capital is closing in on its next big target struggling with too much debt – the country’s second-largest hospital operator Healthscope.

(Batesville, IN) – Hillenbrand Inc. has announced plans to sell a 51 percent stake in its Cincinnati-based subsidiary Milacron LLC, to an affiliate of Boston-based investment firm Bain Capital.